BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16472016)

  • 1. Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200.
    Jenkins CM; Johnson ST; Bellissimo DB; Gottschall JL
    Immunohematology; 2005; 21(4):152-4. PubMed ID: 16472016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
    Judd WJ; Moulds M; Schlanser G
    Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and safe definition of the rhesus-negative donor on the olympus PK 7200 without the indirect antiglobulin test for weak D.
    Mertens G; Muylle L
    Vox Sang; 1996; 70(4):237-8. PubMed ID: 9123933
    [No Abstract]   [Full Text] [Related]  

  • 5. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
    Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
    Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of commercial anti-D reagents in the identification of partial D variants in Indian population.
    Kulkarni SS; Vasantha K; Gupte SC; Mohanty D; Ghosh K
    Indian J Med Res; 2007 May; 125(5):641-4. PubMed ID: 17642499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHD variants in Flanders, Belgium.
    Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
    Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RHD positive among C/E+ and D-negative blood donors in Tunisia.
    Moussa H; Tsochandaridis M; Kacem N; Chakroun T; Abdelkefi S; Gabert J; Levy A; Jemni Yacoub S
    Transfus Clin Biol; 2014 Dec; 21(6):320-3. PubMed ID: 25458985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak D phenotypes and transfusion safety: where do we stand in daily practice?
    Noizat-Pirenne F; Verdier M; Lejealle A; Mercadier A; Bonin P; Peltier-Pujol F; Fialaire-Legendre A; Tournamille C; Bierling P; Ansart-Pirenne H
    Transfusion; 2007 Sep; 47(9):1616-20. PubMed ID: 17725725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.
    Londero D; Fiorino M; Miotti V; de Angelis V
    Immunohematology; 2011; 27(1):25-8. PubMed ID: 22356483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.
    Kulkarni S; Kasiviswanathan V; Ghosh K
    Blood Transfus; 2013 Jan; 11(1):37-42. PubMed ID: 22871818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood grouping with the Olympus PK7100 testing system.
    Reiss RF; Malavade V; Johnson CL; Hendricks E; Rabin BI; Marsh WL
    Clin Lab Haematol; 1988; 10(4):385-90. PubMed ID: 3150697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic findings of RhD alleles in Egyptians and their clinical implications.
    Hussein E; Teruya J
    Transfus Apher Sci; 2014 Oct; 51(2):184-7. PubMed ID: 25219636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weak D type 2 is the most prevalent weak D type in Portugal.
    Araújo F; Rodrigues MJ; Monteiro F; Chabert T; Tavares G; Sousa G; Storry J; Guimarães JE
    Transfus Med; 2006 Feb; 16(1):63-7. PubMed ID: 16480441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak D types in the Egyptian population.
    Hussein E; Teruya J
    Am J Clin Pathol; 2013 Jun; 139(6):806-11. PubMed ID: 23690125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.